The Flushing Patient
1985; Wiley; Volume: 24; Issue: 1 Linguagem: Inglês
10.1111/j.1365-4362.1985.tb05565.x
ISSN1365-4632
Autores Tópico(s)Medicine and Dermatology Studies History
ResumoInternational Journal of DermatologyVolume 24, Issue 1 p. 549-554 The Flushing Patient Ellen Mooney M.D., Corresponding Author Ellen Mooney M.D. Departments of Dermatology and Pathology, University of Iceland Faculty of Medicine, Reykjavik, IcelandEllen Mooney M.D., Department of Pathology, Moses H. Cone Memorial Hospital, 1200 North Elm Street, Greensboro, NC 27401.Search for more papers by this author Ellen Mooney M.D., Corresponding Author Ellen Mooney M.D. Departments of Dermatology and Pathology, University of Iceland Faculty of Medicine, Reykjavik, IcelandEllen Mooney M.D., Department of Pathology, Moses H. Cone Memorial Hospital, 1200 North Elm Street, Greensboro, NC 27401.Search for more papers by this author First published: January 1985 https://doi.org/10.1111/j.1365-4362.1985.tb05565.xCitations: 11AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Wilkin JK. Flushing reactions consequences and mechanisms. Ann Intern Med. 1981; 95: 468–476. 2 Wolff PH. Vasomotor sensitivity to alcohol in diverse mongoloid populations. Am J Hum Genet. 1973; 25: 193–199. 3 Seto A, Tricomi S, Goodwin DW, et al. Biochemical correlates of ethanol-induced flushing in orientals. J Stud Alcohol. 1978; 39: 1–11. 4 Sanders B, Danko GP, Ching B. Cardiovascular responses of oriental and Caucasian men to alcohol. J Stud Alcohol. 1980; 41: 496–508. 5 Granerus G, Svensson SE, Wetterquist H. Histamine in alcoholic drinks. Lancet. 1969; 1: 1320. 6 Bauer M, Rabens SF. Trichloroethylene toxicity. Int J Dermatol. 1977; 16: 113–116. 7 Riihimäki V, Laine A, Savolainen K, Sippel H. Acute solvent-ethanol interactions with special reference to xylene. Scand J Work Environ Health. 1982; 8: 77–79. 8 Hald J, Jacobsen E, Larsen V. The antabuse effect of some compound related to antabuse and cyanamide. Acta Pharmacol Toxicol. 1952; 8: 329–337. 9 Reynolds WA, Lowe FH. Mushrooms and a toxic reaction to alcohol. N Engl J Med. 1965; 272: 630–631. 10 Perman ES. Intolerance to alcohol. N Engl J Med. 1965; 273: 114. 11 Seixas FA. Alcohol and its drug interactions. Ann Intern Med. 1975; 83: 86–92. 12 Jerntorp P, Almér LO. Chlorpropamide-alcohol flushing in relation to macroangiopathy and peripheral neuropathy in noninsulin dependent diabetics. Acta Med Scand [Suppl] 1981; 656: 33–36. 13 Barnett AH, Leslei RDG, Pyke DA. Chlorpropamide-alcohol flushing and proteinuria in non-insulin dependent diabetics. Br Med J. 1981; 282: 522–523. 14 Reeves DS, Davis AJ. Antabuse effect with cephalosporins. Lancet. 1980; 2: 540. 15 Portier H, Chalopin JM, Freysz M, et al. Interactions between cephalosporins and alcohol. Lancet. 1980; 2: 263. 16 Drummer S, Hauser WE, Remington JS. Antabuse-like effect of β-lactam antibiotics. N Engl J Med. 1980; 303: 1417–1418. 17 McMahon FG. Disulfiram-like reactions to a cephalosporin. JAMA. 1980; 243: 2397. 18 Neu HC, Prince AS. Interaction between moxalactam and alcohol. Lancet. 1980; 1: 1422. 19 Adamson AR, Grahame-Smith DG, Peart WS, et al. Pharmacological blockade of carcinoid flushing provoked by cate-cholamines and alcohol. Lancet. 1969; 2: 293–297. 20 Dibacco RS, DeLeo VA. Mastocytosis and the mast cell. J Am Acad Dermatol. 1982; 7: 709–722. 21 Cunliffe WJ. The skin and the nervous system. In: A Rook, DS Wilkinson, eds. Textbook of dermatology. 3rd ed. Oxford : Blackwell, 1979: 2019. 22 Parker F, Otland F. The mastocytosis syndrome. In: TB Fitzpatric, AZ Eisen, IM Freidberg, et al., eds. Dermatology in general medicine. 2nd ed. New York : McGraw-Hill, 1979: 778–782. 23 Moetrel CG, Beahrs OH, Woolner LB, et al. Malignant carcinoid syndrome” associated with noncarcinoid tumors. N Engl J Med. 1965; 273: 244–248. 24 Brewin TB. Alcohol intolerance in neoplastic disease. Br Med J. 1966; 2: 437–441. 25 Anonymous. Hot flushes (editorial). Lancet. 1981; 2: 965–966. 26 Hutton JD, Jacobs HS, Murray MAF, et al. Relation between plasma aestrone and aestradiol and climacteric symptoms. Lancet. 1978; 1: 678–681. 27 Casper RF, Yen SSC, Wilkes MM. Menopausal flushes: a neu- roendocrine link with pulsatile luteinizing hormone secretion. Science. 1979; 205: 823–825. 28 Meldrum DR, Tataryn IV, Frumar AM, et al. Gonadotropins, estrogens and adrenal steroids during the menopausal hot flash. J Clin Endocrinal Metab. 1980; 50: 685–689. 29 Mulley G, Mitchell JRA, Tattersal RB. Hot flushes after hypo-physectomy. Br J Med. 1977; 2: 1062. 30 Genassani AR, Facchinetti F, Ricchi-Danero MG, et al. Beta- lipotropin and beta-endorphin in physilogical and surgical menopause. J Endocrinol Invest. 1981; 4: 375–378. 31 Erlik Y, Meldrum DR, Judd HL. Estrogen levels in postmenopausal women with hot flashes. Obstet Gynecol. 1982; 59: 403–407. 32 Silverman RW, Bajorek JG, Lomax P, et al. Monitoring the pathophysiological correlates of postmenopausal hot flashes. Maturitas. 1981, 3: 39–46. 33 Metzger WJ, Kaplan AP, Beaven M, et al. Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity. J Allergy Clin Immunol. 1976; 57: 605–608. 34 Houser DD, Arbesman CE, Ito K, et al. Cold uricaria: immunologic studies. Am J Med. 1970; 49: 23–33. 35 Hambrick GW, Epstein E, Philadelphia Dermatology Society. Cold urticaria: Arch Dermatol. 1960; 81: 1048–1049. 36 Brandt NJ, Terenius L, Jacobsen BB, et al. Hyper-endorphin syndrome in a child with necrotizing encephalomyelopathy. N Engl J Med. 1980; 303: 914–916. 37 Kissane JM. Pathology of infancy and childhood. 2nd ed. St. Louis : CV Mosby, 1975: 581. 38 Wilkin JK. Oral thermal induced flushing in erythematelangiec- tatic rosacea. J Invest Dermatol. 1981, 76: 15–18. 39 Feldman JM, Jones RS. Carcinoid syndrome from gastrointestinal carcinoids without liver metastasis. Ann Surg. 1982; 196: 33–37. 40 Feldman JM, Davis JA. Radioenzymatic assay of platelet serotonin, dopamine and norepinephrine in subjects with normal and increased seratonin production. Clin Chim Acta. 1981; 109: 275–283. 41 Wingert TD, Morley JE, Hershman JM. Histamine antagonists and carcinoid flush. N Engl J Med. 1980; 302: 234. 42 Roberts LJ, Bloomgarden ZT, Marney SR, et al. Histamine release from a gastric carcinoid: Provocation by pentagastrin and inhibition by somatostatin. Gastroenterology. 1984; 84: 272–275. 43 Frölich JC, Bloomgarden ZT, Oates JA, et al. The carcinoid flush: provocation by pentagastrin and inhibition by somatostatin. N Engl J Med. 1978; 299: 1055–1057. 44 Smith AG, Greaves MW. Blood prostoglandin activity associated with nonadrenaline-provoked flush in the carcinoid syndrome. Br J Dermatol. 1974; 90: 547–551. 45 Horwitz D, Lovenberg W, Engelman K, et al. Monoamine oxidase inhibitors, tyramine and cheese. JAMA. 1964; 288: 1108–1111. 46 van der Veer, JS, Choufour JC, Querido A, et al. Metastasising islet-cell tumor of the pancreas associated with hypoglycaemia and carcinoid syndrome. Lancet. 1964; 1: 1416–1419. 47 Plaksin J, Landau Z, Coslovsky R. A carcinoid-like syndrome caused by a prostaglandin-secreting renal cell carcinoma. Arch Intern Med. 1980; 140: 1095–1096. 48 Fahrenkurg J. Vasocative intestinal polypeptide. Clin Gastroenterol. 1980; 9: 633–643. 49 Said SI. Evidence for secretion of vasoactive intestinal peptide by tumors of pancreas, adrenal medulla, thyroid and lung: support for the unifying APUD concept. Clin Endrocinol. 1976; 5: 201s–204s. 50 Modlin IM, Lamers CBH. Multiple endocrine neoplasia. S Afr Med J. 1979; 56: 521–525. 51 Cunliffe WJ, Black MM, Hall R, et al. A calcitonin-secreting thyroid carcinoma. Lancet. 1968; 2: 63–66. 52 Murray JS, Paton RR, Pope C. Pancreatic tumor associated with flushing and diarrhea. N Engl J Med. 1961; 264: 436–439. 53 Harrison MT, Montgomery DAD, Ramsey AS, et al. Cushing's syndrome with carcinoma of bronchus and with features suggesting carcinoid tumor. Lancet. 1957; 1: 23–25. 54 Williams ED, Azzopardi JG. Tumors of the lung and the carcinoid syndrome. Thorax. 1960; 15: 30–36. 55 Szweda JA, Abraham JP, Fine G, et al. Systemic mast cell disease: a review and report of three cases. Am J Med. 1962; 32: 227–239. 56 Sy WM, Bonventre MV, Camera A. Bone scan in mastocytosis: case report. J Nucl Med. 1976; 17: 699–701. 57 Roberts LJ, Sweetman BJ, Lewis RA, et al. Increased prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med. 1980; 303: 1400–1404. 58 Rosenthal S, Schwartz JH, Cancellos GP. Basophilic chronic granulocytic leukemia. Br J Haematol. 1977; 26: 367–372. 59 Nickerson M. Vasodilator drugs. In: LS Goodman, A Gilman eds., The pharmacological basis of therapeutics. 5th ed. New York : Macmillan, 1975: 729. 60 Reif-Lehrer L. Possible significance of adverse reactions to glutamate in humans. Fed Proc. 1976; 35: 2205–2211. 61 Andersson RGG, Aberg G, Brattsand R, et al. Studies on the mechanisms of flush induced by nicotinic acid. Acta Pharmacol Toxicol. 1977; 41: 1–10. 62 Gustafson A. Treatment of hyperlipoproteinemia type II with etofibrate. Int J Clin Pharmacol Biopharm. 1979; 17: 498–502. 63 Sigroth K. Effect of clonidine on nicotinic-acid flushing. Lancet. 1974; 2: 58. 64 Svedmyr N, Heggelund A, Aberg G. Influence of indomethacin in flush induced by nicotinic acid in man. Acta Pharmacol Toxicol. 1977; 41: 397–400. 65 Phillips WS, Lightman SL. Is cutaneous flushing prostaglandin mediated Lancet. 1981; 1: 754–756. 66 Rohte Von, O, Thormählen D, Ochlich P. Tierexperimentelle Vorsuche zur Klärung des Machanismus des Nikotinsäure-Flush. Arzneimittelforsch. 1977; 27: 2347–2352. 67 Cohen RA, Coffman JD. Naloxone reversal of morphine-induced peripheral vasodilatation. Clin Pharmacol Ther. 1980; 28: 541–544. 68 Stubbs WA, Delitala G, Jones A, et al. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet. 1978; 2: 1225–1227. 69 Kennedy BJ. Metabolic and toxic effects of mithramycin during therapy. Am J Med. 1970; 49: 494–503. Citing Literature Volume24, Issue1January 1985Pages 549-554 ReferencesRelatedInformation
Referência(s)